NYSE:CVSHealthcare
A Look At CVS Health (CVS) Valuation After Tennessee’s FAIR Rx Act Targets Its Integrated Model
The FAIR Rx Act passed by the Tennessee General Assembly has put CVS Health (CVS) at the center of a regulatory test, challenging its combined pharmacy benefit manager and retail pharmacy model in a key state.
See our latest analysis for CVS Health.
The FAIR Rx Act headlines are landing at a time when CVS Health’s 30 day share price return of 7.98% contrasts with a weaker 90 day share price return of 6.11% and a stronger 1 year total shareholder return of 23.68%. Recent regulatory headlines...